Rockwell Medical, Inc. (NASDAQ:RMTI) was the target of unusually large options trading on Friday. Stock investors acquired 696 put options on the company. This represents an increase of approximately Infinity compared to the typical daily volume of 0 put options.
A number of institutional investors and hedge funds have recently made changes to their positions in RMTI. Athos Capital Ltd acquired a new position in Rockwell Medical during the 3rd quarter worth about $6,834,000. Vanguard Group Inc. lifted its holdings in Rockwell Medical by 4.9% during the 1st quarter. Vanguard Group Inc. now owns 1,990,057 shares of the company’s stock worth $12,458,000 after buying an additional 93,589 shares during the period. State Street Corp lifted its holdings in Rockwell Medical by 7.4% during the 2nd quarter. State Street Corp now owns 903,142 shares of the company’s stock worth $7,160,000 after buying an additional 62,094 shares during the period. GSA Capital Partners LLP lifted its holdings in Rockwell Medical by 216.8% during the 2nd quarter. GSA Capital Partners LLP now owns 76,566 shares of the company’s stock worth $607,000 after buying an additional 52,400 shares during the period. Finally, Geode Capital Management LLC lifted its holdings in Rockwell Medical by 9.7% during the 1st quarter. Geode Capital Management LLC now owns 371,700 shares of the company’s stock worth $2,326,000 after buying an additional 32,964 shares during the period. 21.73% of the stock is currently owned by hedge funds and other institutional investors.
A number of equities research analysts recently weighed in on the company. Zacks Investment Research upgraded Rockwell Medical from a “sell” rating to a “hold” rating in a research report on Wednesday, October 11th. BidaskClub lowered Rockwell Medical from a “hold” rating to a “sell” rating in a research report on Friday, July 28th. Finally, Ifs Securities assumed coverage on Rockwell Medical in a research report on Monday, August 14th. They set a “strong-buy” rating and a $11.00 price objective on the stock.
Rockwell Medical (NASDAQ:RMTI) opened at $6.13 on Wednesday. Rockwell Medical has a twelve month low of $5.06 and a twelve month high of $8.98.
Rockwell Medical (NASDAQ:RMTI) last announced its earnings results on Wednesday, November 8th. The company reported ($0.10) EPS for the quarter, hitting the Thomson Reuters’ consensus estimate of ($0.10). The firm had revenue of $14.63 million for the quarter, compared to the consensus estimate of $13.33 million. Rockwell Medical had a negative return on equity of 46.63% and a negative net margin of 39.28%. The business’s quarterly revenue was up 14.2% compared to the same quarter last year. During the same period in the previous year, the business earned ($0.09) EPS. equities analysts predict that Rockwell Medical will post -0.44 EPS for the current year.
TRADEMARK VIOLATION NOTICE: “Investors Purchase Large Volume of Put Options on Rockwell Medical (RMTI)” was published by Transcript Daily and is the property of of Transcript Daily. If you are accessing this report on another site, it was illegally copied and republished in violation of US and international trademark and copyright laws. The original version of this report can be accessed at https://transcriptdaily.com/2017/11/15/investors-purchase-large-volume-of-put-options-on-rockwell-medical-rmti.html.
Rockwell Medical Company Profile
Rockwell Medical, Inc (Rockwell) is a biopharmaceutical company targeting end-stage renal disease (ESRD) and chronic kidney disease (CKD) with products and services for the treatment of iron deficiency, secondary hyperparathyroidism and hemodialysis. The Company operates through the hemodialysis market segment, which involves the manufacture, sale and distribution of hemodialysis products to hemodialysis clinics, including pharmaceutical, dialysis concentrates, dialysis kits and other ancillary products used in the dialysis process.
Receive News & Ratings for Rockwell Medical Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Rockwell Medical Inc. and related companies with MarketBeat.com's FREE daily email newsletter.